Navigation Links
Smartphone app reads blood oxygen levels to hospital standards, advances to global obstetrics tests
Date:3/9/2014

Private and public investors are injecting $2 million into a Canadian mobile health innovation that offers hope of preventing thousands of deaths and improving the health of expectant mothers, newborns and children throughout the developing world.

LionsGate Technologies (LGTmedical), a Vancouver-based social enterprise, has secured its first major financial backers to scale up development of the Phone Oximeter, an app and medical sensor that turns a non-specialist, community-level health worker's smartphone, tablet computer or laptop into an affordable and simple but sophisticated medical-grade diagnostic tool typically available in the developing world only in some hospitals.

Mr. Irfhan Rajani, CEO of Vancouver-based Coleco Investments, leads a $1 million angel investment in the device, to be matched with a $1 million grant from Grand Challenges Canada -- the first such investment under a new $10 million strategic partnership between Grand Challenges Canada and the Department of Foreign Affairs, Trade and Development Canada (DFATD).

"Our Government is promoting innovative approaches to addressing the world's most urgent needs in both global health and international development, including leveraging private sector investment and partnerships that focus on results," said the Hon. Christian Paradis, Canadian Minister of International Development and La Francophonie. "This newest investment is a precise fit with the Prime Minister's global commitment, through the Muskoka Initiative, to improve the health and lives of mothers and children in the world's poorest countries."

Developed by scientists Drs. Mark Ansermino, Guy Dumont and Peter von Dadelszen of the University of British Columbia, the device measures blood oxygen levels through a light sensor attached to a person's fingertip. This technique is known as pulse oximetry.

The Phone Oximeter, using a predictive score, can accurately identify an estimated 80% of cas
'/>"/>

Contact: Terry Collins
tc@tca.tc
416-538-8712

Lode Roels
lode.roels@grandchallenges.ca
647-328-2021
Grand Challenges Canada

Tom Walker
tom.walker@lgtmedical.com
778-968-8582
LGTmedical


Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Smartphone app aids college-age women in abusive relationships
2. RF Safe Launches Smartphone Flip Cases for Apple iPhone to Shield Cell Phone Radiation
3. RF Safe Launches Samsung Smartphone Flip Cases To Shield Cell Phone Radiation
4. Proliferation of Smartphones Drives the Market for Mobile Medical Apps, According to a New Trend Report Published by Global Industry Analysts, Inc.
5. RF Safe Cell Phone Radiation Shield, Ferrite Bead and Air-tube Headsets Reduce Smartphone Radiation Risk
6. After Christmas Sale at RF Safe on Air-Tube Headsets That Prevent Radiation Hazards for Kids That Got a New Smartphone for Christmas
7. New tech lets cholesterol-tracking smartphone users take lifesaving selfies
8. TIRR Memorial Hermann Uses Smartphones to Reduce Noise from Overhead Paging
9. Cyber Monday 2013 Smartphone, Tablet Deals – iPad Mini, Kindle, iPad Air, Nexus, Galaxy S4, Iphone 5 as Recommended by Daily News Deals
10. Smartphone apps lack proven strategies to help smokers quit
11. PriceAngels.com Announces Great Discounts On Its i9500 S4 Smartphone
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smartphone app reads blood oxygen levels to hospital standards, advances to global obstetrics tests
(Date:9/2/2014)... (PRWEB) September 02, 2014 According ... http://www.idataresearch.com ), the leading global authority in medical ... market is expected to grow to over ... by an increase in the number of procedures ... kidney stones. This market includes TURP devices, laser ...
(Date:9/2/2014)... September 02, 2014 Nanomedicine is ... in diagnosing, treating and/or prevention of diseases and ... treating cardiovascular, neurological, and oncology diseases. , ... pertaining to various nanoparticles, their medical usages, and ... exists considerable scope for research in this domain, ...
(Date:9/2/2014)... On Saturday, September 6, 2014, The Concilio will present ... vida! Get Up! Get Moving!®. This event promotes Hispanic family ... for people of all ages and all sizes. The event, ... held at Kiest Park Recreation Center, 3080 S. Hampton Road, ... “Since 2007, we have partnered with National Alliance for Hispanic ...
(Date:9/2/2014)... 2014 Durable Medical Goods manufacture ... leasing and financing company LeaseQ, Inc. to help customers ... Since late 2012, LeaseQ’s breakthrough finance shopping platform has ... they need to run their business. , Said ... enable the ThermoTek sales team to provide customers faster ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group (AHDPG) ... its ICD-10 Medical Coding Bridge Program. The purpose of ... confidence to students who are seeking to launch an ... with the uncertainty brought on by the federal government’s ... 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple and ...
Breaking Medicine News(10 mins):Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 3Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3
... public health researchers discuss whether or not the public ... (Swedish snus) is less hazardous to health than smoking ... information, Carol Gartner and Wayne Hall (University of Queensland, ... be widelyused as an alternative to cigarettes in Sweden, ...
... that girls as young as 15 are resorting to the drug ... ,The Amphetamine drugs that are snorted and injected contract appetite ... ,Robin Herne with Suffolk's Drug and Alcohol Action Team, said ... ,Herne warned that the drug can lead to binge eating, ...
... save your heart, for a new study has found ... ,Dr Alyson Mitchell and his team at ... using standardised farming techniques for the ten-year study. ... double the amount of flavonoids than compared to the ...
... risk of childhood asthma by as much as 70 ... five countries . ,The culprit gene, called ... online on Wednesday by the British science journal Nature, ... the United States and Austria joined the DNA trawl, ...
... million dollar space programme, will carry out scientific research ... in outer space, reports said Wednesday. ... the crystallisation of protein, said Abdul Rahman Abdul Jamal, ... University of Malaysia. ,"The research is aimed ...
... in St. Louis, Missouri, have found two antidotes which, ... deadliest poisons like Ricin, cholera toxin, and shiga toxin. ... E. coli bacteria, these toxins travel backwards through a ... endoplasmic reticulum before interrupting protein synthesis. ...
Cached Medicine News:Health News:Major Gene Link Seen to Childhood Asthma 2
(Date:9/2/2014)... , Spanien, September 2, 2014 ... Das auf dem ESC-Kongress 2014 präsentierte ... Behandlung und Behandlungsergebnisse von schlaganfallgefährdeten Patienten ... Die Daten der ... Patienten, einer innovativen und unabhängigen Forschungsinitiative ...
(Date:9/2/2014)... September 2, 2014 , ... 2014 provide insight into treatment and outcomes of ... practice --   Data from nearly ... in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent ... strategies for atrial fibrillation (AF) patients remain sub-optimal ...
(Date:9/2/2014)... , Sept. 2, 2014 Particle Sciences, the ... its investment in development and manufacturing capabilities with the ... Karl Mueller , Particle Sciences, Associate Director Clinical Production, ... adding clean room square footage, equipment and staff across ... The company now has over 6000ft 2 of ...
Breaking Medicine Technology:Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
... , ... The Gamida Cell-Teva Joint Venture,(JV) announced today that the ... registration, Phase,III clinical trial of StemEx (called ExCell) and has recommended ... data analysis is,anticipated to take place during Q2 2010. StemEx is ...
... , Feb. 9 CareFusion Corp. (NYSE: ... from continuing operations for the three and six months ended ... during our second quarter and performed ahead of our expectations," said ... spending made modest improvements during the quarter and we continued to ...
Cached Medicine Technology:Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3CareFusion Reports Second Quarter Results 2CareFusion Reports Second Quarter Results 3CareFusion Reports Second Quarter Results 4CareFusion Reports Second Quarter Results 5CareFusion Reports Second Quarter Results 6CareFusion Reports Second Quarter Results 7CareFusion Reports Second Quarter Results 8CareFusion Reports Second Quarter Results 9CareFusion Reports Second Quarter Results 10CareFusion Reports Second Quarter Results 11CareFusion Reports Second Quarter Results 12CareFusion Reports Second Quarter Results 13CareFusion Reports Second Quarter Results 14CareFusion Reports Second Quarter Results 15CareFusion Reports Second Quarter Results 16CareFusion Reports Second Quarter Results 17CareFusion Reports Second Quarter Results 18
... PowerSuite holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
... VersaPulse PowerSuite holmium laser combines excellent ... precise, virtually bloodless procedures. It is ... and gall bladder stones of all ... surgical tool. Because its laser light ...
... perfecting mini-invasive endoscopic methods for ensuring extremely ... considerable social impact. The use of these ... and represents a valid backup in cutting ... family of Nd:YAG lasers is growing, developing ...
... hair removal for all skin ... Used for leg and facial ... Offers a large spot sizes ... fast treatment. An optional ...
Medicine Products: